News
PRCT
29.25
+1.63%
0.47
Weekly Report: what happened at PRCT last week (0601-0605)?
Weekly Report · 2d ago
BTIG Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)
TipRanks · 06/03 11:30
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Vera Therapeutics (VERA) and Resmed (RMD)
TipRanks · 06/03 11:30
Analyst Reiterates Buy as Management Reaffirms 2026 Targets and Commercial Restructuring Begins to Deliver Benefits
TipRanks · 06/03 11:24
Weekly Report: what happened at PRCT last week (0525-0529)?
Weekly Report · 06/01 09:59
PROCEPT BioRobotics (PRCT) Receives a Buy from TD Cowen
TipRanks · 06/01 05:35
PROCEPT BioRobotics Announces Two Milestones In Its WATER IV Prostate Cancer Clinical Program
Benzinga · 05/28 12:18
PROCEPT BIOROBOTICS® ADVANCES PROSTATE CANCER PROGRAM WITH WATER IV STUDY ENROLLMENT COMPLETION AND EXPANDED IDE APPROVAL
Reuters · 05/28 12:00
Weekly Report: what happened at PRCT last week (0518-0522)?
Weekly Report · 05/25 10:02
Weekly Report: what happened at PRCT last week (0511-0515)?
Weekly Report · 05/18 10:02
Aquablation Gains Stronger Guideline Backing, Supporting Procept’s Long-Term Growth and Buy Rating
TipRanks · 05/14 16:46
PROCEPT BioRobotics (PRCT) Gets a Buy from TD Cowen
TipRanks · 05/14 15:35
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), PROCEPT BioRobotics (PRCT) and Lineage Therap (LCTX)
TipRanks · 05/13 10:50
Weekly Report: what happened at PRCT last week (0504-0508)?
Weekly Report · 05/11 10:00
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Incyte (INCY)
TipRanks · 05/04 19:50
Weekly Report: what happened at PRCT last week (0427-0501)?
Weekly Report · 05/04 09:58
Procept Biorobotics Charts Growth Amid Profit Pressures
TipRanks · 05/01 00:47
Procept BioRobotics EVP, CTO Barry Templin files initial beneficial ownership statement
PUBT · 04/30 22:10
Procept BioRobotics to present at Bank of America Health Care Conference
PUBT · 04/30 20:10
Piper Sandler Reiterates Overweight on PROCEPT BioRobotics, Raises Price Target to $35
Benzinga · 04/30 17:18
More
Webull provides a variety of real-time PRCT stock news. You can receive the latest news about Procept Biorobotics Corp through multiple platforms. This information may help you make smarter investment decisions.
About PRCT
PROCEPT BioRobotics Corporation is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The Company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are advanced, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia (BPH). It designed Aquablation therapy to deliver outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH that is independent of prostate size and shape and delivers resection independent of surgeon experience. It manufactures the robotic systems, the single-use disposable handpiece, integrated scope and other accessories at its facility in San Jose, California. Each robotic system is shipped to its customers with a third-party manufactured ultrasound system and probe.